Abstract:BackgroundPrevious studies have investigated the sustained aberrantly activated Interleukin-6 (IL-6)/signal transducer and activator of transcription 3 (STAT3) signaling pathway is crucial for pancreatic cancer growth and metastasis. Suppressor of cytokine signaling 3 (SOCS3), as a key negative feedback regulator of this signaling pathway, is usually down-regulated in various cancers. In the present study, we aim at exploring the biological function and the underlying molecular regulation mechanisms of SOCS3 in pancreatic cancer.MethodsThe expression of SOCS3 and other genes in pancreatic cancer was examined by Quantitative real-time PCR, western blotting and immunohistochemical staining. The interaction between pSTAT3 and DNA Methyltransferase 1 (DNMT1) was investigated by co-immunoprecipitation assay. Luciferase reporter assay was used to investigate the transcriptional regulation of pSTAT3 and DNMT1 on the SOCS3 gene. The effects of SOCS3 on the biological behavior of pancreatic cancer cells were assessed both in vitro and vivo. Furthermore, we performed a comprehensive analysis of the expression of SOCS3 in a pancreatic cancer tissue microarray (TMA) and correlated our findings with pathological parameters and outcomes of the patients.ResultsWe showed that SOCS3 expression was decreased in phosphorylated STAT3 (pSTAT3)-positive tumors and was negatively correlated with pSTAT3 in pancreatic cancer cells. We also found that IL-6/STAT3 promoted SOCS3 promoter hypermethylation by increasing DNMT1 activity; silencing DNMT1 or 5-aza-2-deoxycytidine (5-AZA) treatment could reverse the down-regulation of SOCS3 mediated by IL-6. Using co-immunoprecipitation and luciferase reporter assays, we found that STAT3 recruited DNMT1 to the promoter region of SOCS3 and inhibited its transcriptional activity. Overexpression of SOCS3 significantly inhibited cell proliferation, which may be due to the increase in G1-S phase arrest; overexpression of SOCS3 also inhibited cell migration and invasion as well as tumorigenicity in nude mice. Pancreatic cancer tissue microarray analysis showed that high SOCS3 expression was a good prognostic factor and negatively correlated with tumor volume and metastasis.ConclusionWe demonstrated that activated IL-6/STAT3 signaling could induce SOCS3 methylation via DNMT1, which led to pancreatic cancer growth and metastasis. These data also provided a mechanistic link between sustained aberrantly activated IL-6/STAT3 signaling and SOCS3 down-regulation in pancreatic cancer. Thus, inhibitors of STAT3 or DNMT1 may become novel strategies for treating pancreatic cancer.

Relationship Between Suppressor of Cytokine Signaling -3 and Cell Migration and Invasion

The Role of Suppressor of Cytokine Signaling 3 in Inflammatory Bowel Disease and Its Associated Colorectal Cancer

miR-22 promotes immunosuppression via activating JAK/STAT3 signaling in cutaneous squamous cell carcinoma

Interference of Suppressor of Cytokine Signaling 3 Promotes Epithelial-Mesenchymal Transition in MHCC97H Cells

Suppressor of cytokine signaling 6 in cancer development and therapy: Deciphering its emerging and suppressive roles

The Role of Microtubule-Associated Protein 1s in Socs3 Regulation of Il-6 Signaling

Role of Suppressor of Cytokine Signaling 3 in the Immune Modulation of Mesenchymal Stromal Cells

SOCS3 as a potential driver of lung metastasis in colon cancer patients

Silencing SOCS3 Could Inhibit TNF-α Induced Apoptosis in 3T3-L1 and Mouse Preadipocytes

High Suppressor Of Cytokine Signaling-3 Expression Impairs Stat3-Dependent Protective Effects Of Interleukin-22 In Ulcerative Colitis In Remission

Restoration of SOCS3 Suppresses Human Lung Adenocarcinoma Cell Growth by Downregulating Activation of Erk1/2, Akt Apart from STAT3

The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma

SOCS3 Inhibiting Migration of A549 Cells Correlates with PYK2 Signaling in Vitro

Suppressor of Cytokine Signaling-1 and Lung Diseases

Sec3 Knockdown Inhibits TGF-β Induced Epithelial-Mesenchymal Transition Through the Down-Regulation of Akt Phosphorylation in A549 Cells.

Proline-rich Region in Immune Suppression Protein SOCS3 is Required for Its Biological Functions

[SOCS3: a Potential Therapeutic Target for Many Human Diseases].

Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis

Silencing SOCS3 expression's inhibitition on TNF-α induced apoptosis in 3T3-L1 preadipocytes

CUEDC2 (CUE Domain-containing 2) and SOCS3 (suppressors of Cytokine Signaling 3) Cooperate to Negatively Regulate Janus Kinase 1/signal Transducers and Activators of Transcription 3 Signaling

Comprehensive analysis of suppressor of cytokine signaling proteins in human breast Cancer